Bill Hawkins predicts “mild pain” after the FDA’s 510(k) overhaul

Medtronic’s Hawkins: 510(k) changes to be ‘neutral to slightly negative’ (MedCityNews)

Outgoing Medtronic (NYSE:MDT) Chief Executive Bill Hawkins is predicting only mild pain when the federal government unveils changes to the 510(k) rules governing approval for most medical devices.